Press release content from Business Wire. The AP news staff was not involved in its creation.
BIOCORP Signs Two New Partnerships With Mallya Technology
February 17, 2021 GMT
Regulatory News:
BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME) (Paris:ALCOR), a French company specialized in the design, development and manufacturing of innovative medical devices, today announces the signature of new partnerships with Health2Sync and SocialDiabetes, companies headquartered in Taiwan and Spain, respectively.
These two partnerships involve the integration of Mallya, the connected device dedicated to insulin pens, with the digital applications developed by Health2Sync and SocialDiabetes to improve the quality of care for patients with diabetes.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Vafa Jamali Appointed as CEO of “NewCo”, New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet
February 16, 2021 GMT
(PRNewsfoto/Zimmer Biomet Holdings, Inc.)
WARSAW, Ind., Feb. 16, 2021 /PRNewswire/ Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that after an extensive search, Vafa Jamali has been appointed as CEO of “NewCo”, the independent, publicly traded company that will be created by a previously announced spin off transaction, expected to close in mid-2022. NewCo will be comprised of Zimmer Biomet’s current Spine and Dental businesses.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Results
February 15, 2021 GMT
CINCINNATI (BUSINESS WIRE) Feb 15, 2021
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2020.
Fourth Quarter and Full Year 2020 Financial Results
Revenue for the three months ended December 31, 2020 increased 13.0% to $259.7 million, compared to $229.9 million for the comparable prior-year period. Revenue for the year ended December 31, 2020 increased 7.5% to $925.9 million, compared to $861.0 million for the year ended December 31, 2019. On a constant currency organic basis, revenue for the fourth quarter of 2020 increased 12.2% compared to the fourth quarter of 2019 and increased 7.3% for the year ended December 31, 2020 compared to the year ended December 31, 2019.
Press release content from Business Wire. The AP news staff was not involved in its creation.
BioUtah and the University of Utah’s PIVOT Center Announce Headline Speakers, Agenda for 2021 Virtual Entrepreneur & Investor Life Sciences Summit
February 11, 2021 GMT
SALT LAKE CITY (BUSINESS WIRE) Feb 11, 2021
BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with the University of Utah’s Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center, today announced its agenda and distinguished keynote speaker, J.P. Morgan’s Monica DiCenso, for the 2021 Virtual Entrepreneur & Investor Life Sciences Summit (E&I Summit) to be held Feb. 25-26. Ms. DiCenso is the managing director and head of Global Investment Opportunities Group at J.P. Morgan Private Bank.